Aggressive Glioblastoma Cells Enhance the Migratory Persistence and Velocity of Less Aggressive Cells to Promote Tumor Dissemination
Small · 2026
DOI: 10.1002/smll.202508142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2026. Verfasst von Fatima-Ezzahra Ait Mohand und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Institute of Biomedical and Oral Research, Hebrew University of Jerusalem, Jerusalem, Israel. Hauptthemen laut MEDLINE: Glioblastoma, Cell Movement, Brain Neoplasms. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebrew University of Jerusalem.
Abstract (Originalsprache)
Glioblastoma multiforme (GBM) is a highly lethal brain cancer driven by aggressive invasion. Epidermal growth factor receptor (EGFR) is frequently amplified in GBM, with the EGFRvIII mutant enhancing the infiltrative features of EGFRwt‐overexpressing cells. Previously, we identified Src as a key cell‐cell communication mediator between EGFRvIII and EGFRwt cells. However, a quantitative biophysical characterization of how EGFRvIII induces this increased infiltration, specifically detailing altered movement parameters and the underlying mechanisms, remains lacking. Using bulk cell culture and 2‐cell microfluidic chips, we quantitatively analyzed the motility of EGFRwt‐overexpressing and EGFRvIII‐expressing GBM cells. We observed that EGFRvIII cells exhibit higher migration velocity and persistence compared to EGFRwt cells, with a highly persistent subpopulation contributing significantly to these differences. Notably, the co‐culture of EGFRvIII cells enhanced the velocity and migration persistence of EGFRwt‐overexpressing cells, leading to increased spreading. Our findings revealed that Src‐mediated cell‐cell communication from EGFRvIII‐expressing to EGFRwt‐overexpressing cells promotes aggressive GBM spreading by increasing both their velocity and migration persistence at the micro‐environmental level. Inhibiting the Src pathway with dasatinib reversed this pro‐migratory effect, markedly reducing their migration persistence. These insights refine our understanding of GBM infiltration and highlight Src inhibition as a promising strategy in EGFRvIII‐positive tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Institute of Biomedical and Oral Research, Hebrew University of Jerusalem, Jerusalem, Israel.
ORCID-Profile: Nataly Kravchenko-Balasha
Förderung
- Hebrew University of Jerusalem
Zitieren
APA
Mohand, F. A., Yemini, S., Gorobetz-Cojocari, I., Rubinstein, A. M., Zemel, A., & Kravchenko-Balasha, N. (2026). Aggressive Glioblastoma Cells Enhance the Migratory Persistence and Velocity of Less Aggressive Cells to Promote Tumor Dissemination. Small. https://doi.org/10.1002/smll.202508142
Vancouver
Mohand FA, Yemini S, Gorobetz-Cojocari I, Rubinstein AM, Zemel A, Kravchenko-Balasha N. Aggressive Glioblastoma Cells Enhance the Migratory Persistence and Velocity of Less Aggressive Cells to Promote Tumor Dissemination. Small. 2026. doi:10.1002/smll.202508142
BibTeX
@article{Mohand2026,
author = {Mohand, Fatima-Ezzahra Ait and Yemini, Shaked and Gorobetz-Cojocari, Irina and Rubinstein, Ariel M and Zemel, Assaf and Kravchenko-Balasha, Nataly},
title = {Aggressive Glioblastoma Cells Enhance the Migratory Persistence and Velocity of Less Aggressive Cells to Promote Tumor Dissemination},
journal = {Small},
year = {2026},
doi = {10.1002/smll.202508142}
}
EUVIMED